Cancer clinical trials in the region Auvergne-Rhône-Alpes

257 currently recruiting clinical trials
Region Auvergne-Rhône-Alpes

Phase 1 / Phase 2 Lung cancer
#NCT04104776
SCLC (Small Cell Lung Cancer) NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic ARID1A 1 2 3 or more
Systemic Treatment-Naive
8 main criterias to confirm
Centre Léon Bérard (Lyon)
Constellation Pharmaceutique
Phase 1 / Phase 2 Breast cancer
#NCT04104776
Locally Advanced Metastatic ARID1A 1 2 3 or more
Systemic Treatment-Naive
7 main criterias to confirm
Centre Léon Bérard (Lyon)
Constellation Pharmaceutique
Phase 1 / Phase 2 Lymphoma
#NCT04104776
B cell lymphoma Large B cell lymphoma None Treated / Controled 2 3 or more
Systemic Treatment-Naive Allogeneic stem cell transplant
8 main criterias to confirm
Centre Léon Bérard (Lyon)
Constellation Pharmaceutique
Phase 1 / Phase 2 Lymphoma
#NCT04104776
T cell lymphoma Peripheral T cell lymphoma None Treated / Controled 1 2 3 or more
Systemic Treatment-Naive Allogeneic stem cell transplant
8 main criterias to confirm
Centre Léon Bérard (Lyon)
Constellation Pharmaceutique
Phase 1 / Phase 2 Prostate cancer
#NCT04104776
Metastatic Castration-resistant ARID1A 1 2 3 or more
Systemic Treatment-Naive
7 main criterias to confirm
Centre Léon Bérard (Lyon)
Constellation Pharmaceutique
Phase 1 / Phase 2 Colon cancer Rectal cancer
#NCT03526835
Adenocarcinoma Locally Advanced Metastatic 1 Chemotherapy
BRAF KRAS G12C KRAS non G12C NRAS Systemic Treatment-Naive
8 main criterias to confirm
Centre Léon Bérard (Lyon)
Merus
Phase 1 / Phase 2 Breast cancer
#NCT04626635
HER2 Negative HR Negative Locally Advanced Metastatic
Systemic Treatment-Naive
7 main criterias to confirm
Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite), Centre Léon Bérard (Lyon), Centre Jean Perrin (Clermont Ferrand )
Regeneron Pharmaceuticals